Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950136-08-000428
Filing Date
2008-02-01
Accepted
2008-01-31 19:06:27
Documents
6
Effectiveness Date
2008-02-01

Document Format Files

Seq Description Document Type Size
1 FORM S-8 file1.htm S-8 533735
2 OPINION OF MORRISON & FOERSTER LLP file2.htm EX-5.1 9826
3 CONSENT OF KESSELMAN & KESSELMAN file3.htm EX-23.2 2890
4 spacer.gif GRAPHIC 43
5 html_protalixlogo.jpg GRAPHIC 30159
6 html_priceletterhead.jpg GRAPHIC 17812
  Complete submission text file 0000950136-08-000428.txt   614693
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-148983 | Film No.: 08565745
SIC: 2836 Biological Products, (No Diagnostic Substances)